<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9095465</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">35046525</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmc">9095465</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">1421</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1038/s41380-021-01421-6</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical characteristics.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1"><label>Table 1</label><caption><p>Demographic and clinical characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Parameter</th><th>HC participants (<italic>n</italic> = 74)</th><th>IBS participants (<italic>n</italic> = 74)</th><th>UC participants (<italic>n</italic> = 74)</th><th><italic>P-value</italic></th></tr></thead><tbody><tr><td>Age(y)</td><td>31(18–57)</td><td>30.5(18–57)</td><td>30(18–60)</td><td>0.944</td></tr><tr><td>Sex</td><td/><td/><td/><td>1</td></tr><tr><td>No. of men</td><td>35</td><td>35</td><td>35</td><td/></tr><tr><td>No. of women</td><td>39</td><td>39</td><td>39</td><td/></tr><tr><td>BMI</td><td>25(19.05–43.59)</td><td>23.45(16.29–36.62)</td><td>23.80(16.90–37.70)</td><td>0.171</td></tr><tr><td>Disease duration</td><td>NaN</td><td>12(1–51)</td><td>11(1–50)</td><td>0.593</td></tr><tr><td>Abdominal symptom intensity 24 h</td><td>0(0–5)</td><td>9(1–17)</td><td>4(0–14)</td><td>&lt; 10<sup>−11</sup>*†‡</td></tr><tr><td>Abdominal symptom unpleasantness 24 h</td><td>0(0–4)</td><td>7.5(0–14)</td><td>3(0–13)</td><td>&lt; 10<sup>−11</sup>*†‡</td></tr><tr><td>PILL score</td><td>3.5(0–21)</td><td>14(3–37)</td><td>12(1–32)</td><td>&lt; 10<sup>−13</sup>*†</td></tr><tr><td>PSS score</td><td>9(0–23)</td><td>18(1–32)</td><td>14(0–29)</td><td>&lt; 10<sup>−8</sup>*†</td></tr><tr><td>PTI score</td><td>NaN</td><td>NaN</td><td>3(0–11)</td><td/></tr><tr><td>VSI score</td><td>0(0–17)</td><td>35.5(2–74)</td><td>25(0–59)</td><td>&lt; 10<sup>−27</sup>*†</td></tr><tr><td>HADS anxiety</td><td>3(0–13)</td><td>7(0–16)</td><td>6(1–13)</td><td>&lt; 10<sup>−10</sup>*†</td></tr><tr><td>HADS depression</td><td>0(0–14)</td><td>2(0–11)</td><td>2(0–13)</td><td>&lt; 10<sup>−7</sup>*†</td></tr><tr><td>STAI state anxiety</td><td>40(34–70)</td><td>49.5(35–70)</td><td>43.5(34–74)</td><td>&lt; 10<sup>−5</sup>*†‡</td></tr><tr><td>STAI trait anxiety</td><td>42(33–71)</td><td>57(36–82)</td><td>47(33–70)</td><td>&lt; 10<sup>−8</sup>*†‡</td></tr><tr><td>SF12 MCS</td><td>55.33(38.46–60.92)</td><td>44.57(16.16–58.27)</td><td>52.70(23.28–61.57)</td><td>&lt; 10<sup>−7</sup>*†‡</td></tr><tr><td>SF12 PCS</td><td>56.42(46.42–61.98)</td><td>52.56(28.33–61.40)</td><td>52.81(24.46–65.40)</td><td>&lt; 10<sup>−8</sup>*†</td></tr></tbody></table><table-wrap-foot><p>Table <xref rid="Tab1" ref-type="table">1</xref> Legend. Unless otherwise indicated, data are median values with ranges (minimum to maximum values) in parentheses. We performed the nonparametric test as values were not normally distributed in at least one group (according to the Lilliefors test). The sex differences were analyzed with the chi-squared test. Other statistical comparisons were performed with Kruskal–Wallis test.</p><p>*Post-hoc comparisons indicated significant differences between the HC group and patients with IBS.</p><p><sup>†</sup>Post-hoc comparisons indicated significant differences between the HC group and patients with UC.</p><p><sup>‡</sup>Post-hoc comparisons showed significant differences between patients with UC and those with IBS.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Parameter</th><th>HC participants (n = 74)</th><th>IBS participants (n = 74)</th><th>UC participants (n = 74)</th><th>P-value</th></tr></thead><tbody><tr><td>Age(y)</td><td>31(18–57)</td><td>30.5(18–57)</td><td>30(18–60)</td><td>0.944</td></tr><tr><td>Sex</td><td/><td/><td/><td>1</td></tr><tr><td>No. of men</td><td>35</td><td>35</td><td>35</td><td/></tr><tr><td>No. of women</td><td>39</td><td>39</td><td>39</td><td/></tr><tr><td>BMI</td><td>25(19.05–43.59)</td><td>23.45(16.29–36.62)</td><td>23.80(16.90–37.70)</td><td>0.171</td></tr><tr><td>Disease duration</td><td>NaN</td><td>12(1–51)</td><td>11(1–50)</td><td>0.593</td></tr><tr><td>Abdominal symptom intensity 24 h</td><td>0(0–5)</td><td>9(1–17)</td><td>4(0–14)</td><td>&lt; 10−11*†‡</td></tr><tr><td>Abdominal symptom unpleasantness 24 h</td><td>0(0–4)</td><td>7.5(0–14)</td><td>3(0–13)</td><td>&lt; 10−11*†‡</td></tr><tr><td>PILL score</td><td>3.5(0–21)</td><td>14(3–37)</td><td>12(1–32)</td><td>&lt; 10−13*†</td></tr><tr><td>PSS score</td><td>9(0–23)</td><td>18(1–32)</td><td>14(0–29)</td><td>&lt; 10−8*†</td></tr><tr><td>PTI score</td><td>NaN</td><td>NaN</td><td>3(0–11)</td><td/></tr><tr><td>VSI score</td><td>0(0–17)</td><td>35.5(2–74)</td><td>25(0–59)</td><td>&lt; 10−27*†</td></tr><tr><td>HADS anxiety</td><td>3(0–13)</td><td>7(0–16)</td><td>6(1–13)</td><td>&lt; 10−10*†</td></tr><tr><td>HADS depression</td><td>0(0–14)</td><td>2(0–11)</td><td>2(0–13)</td><td>&lt; 10−7*†</td></tr><tr><td>STAI state anxiety</td><td>40(34–70)</td><td>49.5(35–70)</td><td>43.5(34–74)</td><td>&lt; 10−5*†‡</td></tr><tr><td>STAI trait anxiety</td><td>42(33–71)</td><td>57(36–82)</td><td>47(33–70)</td><td>&lt; 10−8*†‡</td></tr><tr><td>SF12 MCS</td><td>55.33(38.46–60.92)</td><td>44.57(16.16–58.27)</td><td>52.70(23.28–61.57)</td><td>&lt; 10−7*†‡</td></tr><tr><td>SF12 PCS</td><td>56.42(46.42–61.98)</td><td>52.56(28.33–61.40)</td><td>52.81(24.46–65.40)</td><td>&lt; 10−8*†</td></tr></tbody></table></div>Table ??? Legend. Unless otherwise indicated, data are median values with ranges (minimum to maximum values) in parentheses. We performed the nonparametric test as values were not normally distributed in at least one group (according to the Lilliefors test). The sex differences were analyzed with the chi-squared test. Other statistical comparisons were performed with Kruskal–Wallis test.*Post-hoc comparisons indicated significant differences between the HC group and patients with IBS.†Post-hoc comparisons indicated significant differences between the HC group and patients with UC.‡Post-hoc comparisons showed significant differences between patients with UC and those with IBS.</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Nine brain regions show differences in nodal eigenvector centrality.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2"><label>Table 2</label><caption><p>Nine brain regions show differences in nodal eigenvector centrality.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3">MNI centroid coordinates</th><th rowspan="2">Name of Schaefer-400 parcellation</th><th rowspan="2">Subnetworks</th><th colspan="4">ANCOVA</th><th/></tr><tr><th><italic>x</italic></th><th><italic>y</italic></th><th><italic>z</italic></th><th>HC</th><th>IBS</th><th>UC</th><th><italic>P value</italic></th><th><italic>F</italic></th></tr></thead><tbody><tr><td>−48</td><td>35</td><td>10</td><td>L-ContA-PFClv-1</td><td>Control</td><td>0.033</td><td>0.023</td><td>0.015</td><td>0.00046†</td><td>7.964</td></tr><tr><td>−42</td><td>38</td><td>22</td><td>L-ContA-PFClv-2</td><td>Control</td><td>0.036</td><td>0.021</td><td>0.018</td><td>0.00039*†</td><td>8.156</td></tr><tr><td>39</td><td>33</td><td>38</td><td>R-ContB-PFCld-1</td><td>Control</td><td>0.041</td><td>0.023</td><td>0.018</td><td>0.00003*†</td><td>11.093</td></tr><tr><td>34</td><td>15</td><td>56</td><td>R-ContB-PFCld-4</td><td>Control</td><td>0.048</td><td>0.029</td><td>0.026</td><td>0.00048*†</td><td>7.914</td></tr><tr><td>27</td><td>59</td><td>3</td><td>R-ContB-PFClv-4</td><td>Control</td><td>0.039</td><td>0.023</td><td>0.020</td><td>0.00076*†</td><td>7.424</td></tr><tr><td>−14</td><td>−57</td><td>1</td><td>L-VisPeri-ExStrInf-5</td><td>Visual</td><td>0.033</td><td>0.054</td><td>0.067</td><td>0.00003*†</td><td>10.776</td></tr><tr><td>18</td><td>−45</td><td>−3</td><td>R-VisPeri-ExStrInf-5</td><td>Visual</td><td>0.035</td><td>0.052</td><td>0.064</td><td>0.00034*†</td><td>8.283</td></tr><tr><td>16</td><td>−66</td><td>19</td><td>R-VisPeri-ExStrSup-1</td><td>Visual</td><td>0.039</td><td>0.052</td><td>0.065</td><td>0.00091†</td><td>7.230</td></tr><tr><td>−27</td><td>49</td><td>−14</td><td>L-SalVentAttnB-OFC-1</td><td>Salience/ ventral attention</td><td>0.012</td><td>0.009</td><td>0.004</td><td>0.00106†</td><td>7.073</td></tr></tbody></table><table-wrap-foot><p>Table <xref rid="Tab2" ref-type="table">2</xref> Legend. Nine regions in the control [Cont], visual [Vis], and salience/ventral attention [Sal/VentAttn] network showed significant differences in nodal eigenvector centrality. For the control network, a pattern of HC &gt; IBS &gt; UC was observed, while for the visual network, the observed pattern was HC &lt; IBS &lt; UC. Also, see Fig. <xref rid="Fig3" ref-type="fig">3</xref> for illustration.</p><p>*Post-hoc comparisons indicated significant differences between HC and IBS group.</p><p><sup>†</sup>Post-hoc comparisons indicated significant differences between HC and UC group.</p><p>Abbreviations: <italic>PFClv</italic> Lateral ventral prefrontal cortex; <italic>PFCld</italic> Lateral dorsal prefrontal cortex; <italic>ExStrInf</italic> Inferior peripheral extrastriate; <italic>ExStrSup</italic> Superior peripheral extrastriate; <italic>OFC</italic> Orbitofrontal cortex; <italic>MNI</italic> Montreal Neurological Institute; <italic>UC</italic> Ulcerative colitis; <italic>IBS</italic> Irritable bowel syndrome; <italic>HC</italic> Healthy controls; <italic>L</italic> Left hemisphere; <italic>R</italic> Right hemisphere.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Nine brain regions show differences in nodal eigenvector centrality.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th colspan="3">MNI centroid coordinates</th><th rowspan="2">Name of Schaefer-400 parcellation</th><th rowspan="2">Subnetworks</th><th colspan="4">ANCOVA</th><th/></tr><tr><th>x</th><th>y</th><th>z</th><th>HC</th><th>IBS</th><th>UC</th><th>P value</th><th>F</th></tr></thead><tbody><tr><td>−48</td><td>35</td><td>10</td><td>L-ContA-PFClv-1</td><td>Control</td><td>0.033</td><td>0.023</td><td>0.015</td><td>0.00046†</td><td>7.964</td></tr><tr><td>−42</td><td>38</td><td>22</td><td>L-ContA-PFClv-2</td><td>Control</td><td>0.036</td><td>0.021</td><td>0.018</td><td>0.00039*†</td><td>8.156</td></tr><tr><td>39</td><td>33</td><td>38</td><td>R-ContB-PFCld-1</td><td>Control</td><td>0.041</td><td>0.023</td><td>0.018</td><td>0.00003*†</td><td>11.093</td></tr><tr><td>34</td><td>15</td><td>56</td><td>R-ContB-PFCld-4</td><td>Control</td><td>0.048</td><td>0.029</td><td>0.026</td><td>0.00048*†</td><td>7.914</td></tr><tr><td>27</td><td>59</td><td>3</td><td>R-ContB-PFClv-4</td><td>Control</td><td>0.039</td><td>0.023</td><td>0.020</td><td>0.00076*†</td><td>7.424</td></tr><tr><td>−14</td><td>−57</td><td>1</td><td>L-VisPeri-ExStrInf-5</td><td>Visual</td><td>0.033</td><td>0.054</td><td>0.067</td><td>0.00003*†</td><td>10.776</td></tr><tr><td>18</td><td>−45</td><td>−3</td><td>R-VisPeri-ExStrInf-5</td><td>Visual</td><td>0.035</td><td>0.052</td><td>0.064</td><td>0.00034*†</td><td>8.283</td></tr><tr><td>16</td><td>−66</td><td>19</td><td>R-VisPeri-ExStrSup-1</td><td>Visual</td><td>0.039</td><td>0.052</td><td>0.065</td><td>0.00091†</td><td>7.230</td></tr><tr><td>−27</td><td>49</td><td>−14</td><td>L-SalVentAttnB-OFC-1</td><td>Salience/ ventral attention</td><td>0.012</td><td>0.009</td><td>0.004</td><td>0.00106†</td><td>7.073</td></tr></tbody></table></div>Table ??? Legend. Nine regions in the control [Cont], visual [Vis], and salience/ventral attention [Sal/VentAttn] network showed significant differences in nodal eigenvector centrality. For the control network, a pattern of HC &gt; IBS &gt; UC was observed, while for the visual network, the observed pattern was HC &lt; IBS &lt; UC. Also, see Fig. ??? for illustration.*Post-hoc comparisons indicated significant differences between HC and IBS group.†Post-hoc comparisons indicated significant differences between HC and UC group.Abbreviations: PFClv Lateral ventral prefrontal cortex; PFCld Lateral dorsal prefrontal cortex; ExStrInf Inferior peripheral extrastriate; ExStrSup Superior peripheral extrastriate; OFC Orbitofrontal cortex; MNI Montreal Neurological Institute; UC Ulcerative colitis; IBS Irritable bowel syndrome; HC Healthy controls; L Left hemisphere; R Right hemisphere.</transformed-table></extracted-table></extracted-tables-set>